ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

Sequestration Hurts Kids with Cancer

March 15, 2013

In Congress: HHS Funding Bill Vetoed, Congress, White House Negotiating on Budget

November 12, 1999

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013

Shingleton Nominated To President’s Panel

June 10, 1977

NCI Sponsors Session At ASCO On Clinical Grant Applications

May 3, 1991